Filter
920
Text search:
formulations
Featured
131
249
Language
Document type
444
229
117
56
20
20
13
10
4
3
2
1
Countries / Regions
54
40
29
20
19
17
16
14
12
12
11
11
10
9
9
9
9
8
8
8
8
8
7
7
7
7
6
6
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
307
143
61
61
41
15
15
Toolboxes
94
91
68
60
54
44
43
25
21
21
14
13
10
10
10
10
8
7
7
7
5
4
4
2
WHO Secretariat Information paper July 2016
Ce guide sera particulièrement utile pour les gestionnaires de programme qui concoivent, gèrent et évaluent les systèmes logistique pour les programmes de santé. En outre, décideurs, intervenants du système et toute personne travaillant dans la logistique trouveront dans ce guide une utile a
...
2nd edition
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
2nd edition. WHO's recommendation has not changed: the standard WHO susceptibility tests should remain a primary method by which resistance is detected. However, it was considered necessary to update the existing resistance-monitoring procedures to also highlight the need for operationally meaningfu
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac
...
